[Hepatitis B virus infection status and clinical characteristics in patients with rheumatoid arthritis]

H W Zheng1, Z M Ouyang1, J Pan1

  • 1Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.

Zhonghua Yi Xue Za Zhi
|January 14, 2024
PubMed

Insights

Chronic hepatitis B virus (HBV) infection is common in rheumatoid arthritis (RA) patients in China, affecting 10.1% of those screened. This highlights the need for increased HBV screening and management in RA clinical practice.

Area of Science:

  • Rheumatology and Immunology
  • Infectious Diseases Epidemiology
  • Hepatology

Context:

  • Rheumatoid arthritis (RA) patients are a population of interest for infectious disease screening due to potential immune dysregulation and treatment implications.
  • Hepatitis B virus (HBV) infection prevalence varies geographically and can be influenced by demographic factors and vaccination status.
  • Understanding HBV epidemiology in RA patients is crucial for preventing disease progression and managing treatment-related risks.

Purpose:

  • To determine the prevalence of hepatitis B virus (HBV) infection among rheumatoid arthritis (RA) patients in China.
  • To investigate the association between HBV infection status and RA disease characteristics.
  • To assess the burden of chronic HBV infection and its sequelae within the RA patient cohort.

Summary:

  • A cross-sectional study of 1,461 RA patients in China revealed a 10.1% prevalence of chronic HBV infection, significantly higher in males.
  • Resolved HBV infection was observed in 57.6% of patients, while 32.3% had no evidence of HBV infection.
  • Among those with chronic HBV infection, a small proportion had advanced liver disease, including cirrhosis and hepatocellular carcinoma; 1.0% of all RA patients had abnormal liver function.

Impact:

  • The findings underscore that chronic HBV infection is a significant comorbidity in RA patients in China.
  • Results emphasize the critical need for enhanced HBV screening protocols and proactive management strategies within rheumatology clinical practice.
  • This study provides essential epidemiological data to inform public health initiatives and clinical guidelines for RA patient care in HBV-endemic regions.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
455
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K